A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of IBI363 in Subjects with Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
YASU Research Registry: For Young Adults With Cancer
- Status
- TERMINATED
- Phase
- N/A
BostonGene and Exigent Genomic INsight Study
- Status
- RECRUITING
- Phase
- N/A
Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies
- Status
- RECRUITING
- Phase
- NA
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Status
- RECRUITING
- Phase
- PHASE3
ctDNA for Early Detection of Recurrence in Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of MGC026 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ERK Inhibitor JSI-1187 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
- Status
- RECRUITING
- Phase
- PHASE2
AI-based Medical Device Validation for Early Melanoma Detection
- Status
- COMPLETED
- Phase
- N/A
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1